The pricepoint will not be carved in stone on mount sinai.
Upon initial approval for EPP and only administered to a small population, the price will be high, in the interest of maximizing profits.
As other indications gain approval, the price, we can reasonably expect, will drop in conjunction with the growing base of consumers. This is all in the best interest of the company and its shareholders.
We can criticize management for being too cautious, but we have to also be clear about the risks they would have been taking on our behalf if they had been more aggressive. If the IND had been disapproved, what would the SP be today? The SP fell slightly after IND approval. It would surely have gone below $.10 with a disapproval.
They've been conservative, maybe overcautious. But the result has been that 90% of announcements are completely positive.
- Forums
- ASX - By Stock
- CUV
- who can afford afamelanotide?
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
4.17%
!
$12.25

who can afford afamelanotide?, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.25 |
Change
0.490(4.17%) |
Mkt cap ! $614.0M |
Open | High | Low | Value | Volume |
$11.80 | $12.32 | $11.79 | $1.611M | 133.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | $12.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.25 | 390 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 12.120 |
1 | 5000 | 12.110 |
1 | 100 | 12.100 |
1 | 413 | 12.080 |
2 | 386 | 12.000 |
Price($) | Vol. | No. |
---|---|---|
12.250 | 390 | 1 |
12.320 | 317 | 1 |
12.380 | 500 | 1 |
12.400 | 99 | 1 |
12.450 | 150 | 1 |
Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |